H. Lundbeck

H. Lundbeck and Forest sue Caraco Pharmaceutical Laboratories for patent infringement

Published in Physician Law Weekly, August 9th, 2006

H. Lundbeck, A/S, Forest Laboratories, Inc., and Forest Laboratories Holdings, Ltd., announced that they have filed a lawsuit in the U.S. District Court for the Eastern District of Michigan against Caraco Pharmaceutical Laboratories, Ltd., for infringement of U.S. patent number 34,712.

The patent relates to Forest's Lexapro product.

Forest has received notification from Caraco Pharmaceutical Laboratories, Ltd., that it filed an abbreviated new drug application with a Paragraph IV certification for a generic equivalent to Lexapro.

Howard Solomon, chairman and CEO of Forest, said: "We believe the patent on Lexapro is valid and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2006-08-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry